Elevance Health (ELV) Stock Statistics & Valuation Metrics

Elevance Health has a market cap or net worth of $61.85B. The enterprise value is $118.14B.

Elevance Health has 225,178,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Elevance Health’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 111.83%.

The current PE Ratio of Elevance Health is 11.7. Elevance Health’s PEG ratio is ―.

In the last 12 months, Elevance Health had revenue of 176.81B and earned 5.98B in profits. Earnings per share was 25.81.

In the last 12 months, operating cash flow was 3.47B and capital expenditures -712.30M, giving a free cash flow of 2.76B billion.

Elevance Health pays an annual dividend of $1.71, resulting in a dividend yield of 2.43%

Elevance Health upcoming earnings date is Oct 15, 2025, Before Open (Confirmed).

Elevance Health as a current ratio of 2.01, with Debt / Equity ratio of 69.04%

In the past 12 months, Elevance Health has paid 1.93B in taxes.

Elevance Health EV to EBITDA ratio is 10.38, with an EV/FCF ratio of 23.91.

Elevance Health has $33.86B in cash and marketable securities with $30.19B in debt, giving a net cash position of -$3.67B billion.

Gross margin is 60.40%, with operating margin of 77.62%, and net profit margin of 3.38%.

The average price target for Elevance Health is $367.81, which is 11.43% higher than the current price. The consensus rating is Moderate Buy